nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antifibrotic Therapies: Will We Ever Get There?
|
Thompson, Alexander James |
|
2010 |
12 |
1 |
p. 23-29 |
artikel |
2 |
Antifibrotic Therapies: Will We Ever Get There?
|
Thompson, Alexander James |
|
|
12 |
1 |
p. 23-29 |
artikel |
3 |
Cholestatic Liver Disease in Children
|
Santos, Jorge L. |
|
2010 |
12 |
1 |
p. 30-39 |
artikel |
4 |
Cryptogenic Cirrhosis: What Are We Missing?
|
Caldwell, Stephen |
|
2010 |
12 |
1 |
p. 40-48 |
artikel |
5 |
Genetic Testing for Wilson Disease: Availability and Utility
|
Schilsky, Michael L. |
|
2010 |
12 |
1 |
p. 57-61 |
artikel |
6 |
Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
|
Zein, Claudia O. |
|
2010 |
12 |
1 |
p. 13-22 |
artikel |
7 |
Nontriglyceride Hepatic Lipotoxicity: The New Paradigm for the Pathogenesis of NASH
|
Neuschwander-Tetri, Brent A. |
|
2010 |
12 |
1 |
p. 49-56 |
artikel |
8 |
Phenotypic Expression of Hereditary Hemochromatosis: What Have We Learned from the Population Studies?
|
Gan, Eng K. |
|
2010 |
12 |
1 |
p. 7-12 |
artikel |
9 |
The Healthcare Burden Imposed by Liver Disease in Aging Baby Boomers
|
Davis, Gary L. |
|
2010 |
12 |
1 |
p. 1-6 |
artikel |
10 |
Training for a Career in Hepatology: Which Path to Take?
|
Luxon, Bruce A. |
|
2010 |
12 |
1 |
p. 76-81 |
artikel |
11 |
Treatment of Hepatitis C in 2011: What Can We Expect?
|
Shiffman, Mitchell L. |
|
2010 |
12 |
1 |
p. 70-75 |
artikel |
12 |
Viral Resistance in Hepatitis B: Prevalence and Management
|
Poordad, Fred |
|
2010 |
12 |
1 |
p. 62-69 |
artikel |